Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Salisbury › NPI 1780689463
Lab

Tidalhealth Peninsula Regional, INC.

Tidalhealth Peninsula Regional, INC. was paid $7.63M by Medicaid between Jan 2018 and Dec 2024, across 151 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.

33Billing provider infoTIDALHEALTH PENINSULA REGIONAL, INC.
SALISBURY, MD 21801
33aNPI1780689463assigned 06/17/2005
33bProvider typeClinical Medical Laboratory
28Total paid$7.63M
24GClaims328,610
24DCodes billed151
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Maryland

Rank by total paid#11 of 93
Median peer was paid$430K
This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201867,554$1.34M
201966,350$1.59M
202046,461$988K
202145,771$936K
202244,031$1.11M
202336,536$1.06M
2024incomplete21,907$613K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 29% 16,076 13,736 $2.19M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 14,820 12,892 $1.50M
G0378 Hospital observation service, per hour 17% 2,515 2,066 $1.30M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 5,364 4,725 $947K
99281 Emergency department visit for the evaluation and management, self-limited or minor 5.0% 11,171 9,200 $379K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.4% 3,764 3,355 $256K
97597 1.5% 1,989 916 $117K
H2017 Psychosocial rehabilitation, billed per 15 minutesPsychosocial rehabilitation services, per 15 minutes 1.5% 1,743 162 $113K
80048 Basic metabolic panel (calcium, ionized) 1.4% 23,296 15,717 $107K
80053 Comprehensive metabolic panel <1% 11,244 8,598 $70K
71046 Radiologic examination, chest; 2 views <1% 4,288 3,917 $45K
71045 Radiologic examination, chest; single view <1% 8,420 7,222 $43K
139 more codes
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,467 $36K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 23,861 $34K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 12,180 $31K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,285 $30K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,311 $24K
70450 Computed tomography, head or brain; without contrast material <1% 3,973 $23K
84484 <1% 12,261 $22K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,974 $22K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,847 $21K
81001 <1% 6,608 $19K
94010 <1% 330 $18K
36591 <1% 785 $16K
93971 <1% 103 $14K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,696 $11K
85027 <1% 9,917 $10K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,178 $9K
80061 Lipid panel <1% 1,245 $9K
71275 Computed tomographic angiography, chest, with contrast material <1% 652 $8K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 344 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,711 $8K
80076 <1% 4,727 $7K
A9270 Non-covered item or service <1% 24,069 $7K
83690 <1% 5,406 $6K
36415 Collection of venous blood by venipuncture <1% 1,039 $6K
71250 <1% 273 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 1,447 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,100 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,903 $6K
83735 <1% 8,887 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $6K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 97 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 136 $5K
84443 Thyroid stimulating hormone (TSH) <1% 2,481 $5K
81025 <1% 972 $5K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 68 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,662 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,201 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 982 $4K
J2704 Injection, propofol, 10 mg <1% 3,049 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 1,052 $4K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,535 $4K
81003 <1% 2,650 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 199 $4K
87040 <1% 2,336 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,399 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 588 $3K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 19 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,024 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,058 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 354 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,035 $3K
99213 Doctor's office visit, returning patient (routine) <1% 150 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,371 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,321 $2K
83880 <1% 2,374 $2K
87070 <1% 169 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 378 $2K
94726 <1% 268 $2K
72125 Computed tomography, cervical spine; without contrast material <1% 652 $2K
J1756 Injection, iron sucrose, 1 mg <1% 49 $2K
97162 <1% 177 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,136 $2K
94729 <1% 341 $1K
86140 <1% 1,331 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 81 $1K
93970 <1% 19 $1K
94760 <1% 2,624 $1K
83605 <1% 3,130 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 122 $1K
85610 <1% 2,857 $951.61
94060 <1% 26 $930.60
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 41 $832.27
73630 <1% 16 $811.29
73030 <1% 63 $735.16
90715 <1% 26 $719.63
85007 <1% 2,416 $644.42
85379 <1% 1,213 $607.61
J3475 Injection, magnesium sulfate, per 500 mg <1% 138 $584.25
80050 General health panel <1% 36 $562.91
94799 <1% 922 $560.96
87077 <1% 1,611 $556.12
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 13 $511.66
87186 <1% 1,753 $491.80
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 66 $453.43
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 355 $451.47
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,583 $417.46
85730 <1% 1,174 $411.25
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 40 $371.32
74018 <1% 25 $360.00
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,549 $327.59
82550 <1% 540 $325.30
86850 <1% 1,313 $289.52
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 40 $278.31
86803 <1% 13 $272.87
90686 <1% 44 $269.76
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 542 $253.28
G0008 Administration of influenza virus vaccine <1% 88 $246.96
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 129 $184.48
J1644 Injection, heparin sodium, per 1000 units <1% 567 $182.52
J1940 Injection, furosemide, up to 20 mg <1% 137 $154.49
J1170 Injection, hydromorphone, up to 4 mg <1% 48 $147.51
86900 <1% 1,361 $127.01
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 171 $112.24
82728 <1% 130 $96.80
72020 <1% 13 $95.00
86901 <1% 1,339 $87.59
J3490 Unclassified drugs <1% 114 $69.92
82607 <1% 83 $60.72
90694 <1% 13 $59.75
85652 <1% 181 $57.97
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 13 $53.28
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 801 $51.84
84145 <1% 44 $49.03
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 475 $48.17
84702 <1% 13 $39.00
84466 <1% 114 $30.40
85651 <1% 262 $29.26
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 19 $27.89
J3480 Injection, potassium chloride, per 2 meq <1% 24 $24.69
97166 <1% 28 $24.40
84100 <1% 239 $24.21
J0360 Injection, hydralazine hcl, up to 20 mg <1% 14 $22.87
83615 <1% 78 $22.32
97116 <1% 51 $18.40
J2060 Injection, lorazepam, 2 mg <1% 148 $13.69
83540 <1% 113 $11.40
87205 <1% 155 $3.46
J2550 Injection, promethazine hcl, up to 50 mg <1% 12 $3.01
84132 0% 16 $0.00
73564 0% 31 $0.00
82746 0% 13 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 12 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 83 $0.00
84439 0% 48 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 66 $0.00
96367 0% 22 $0.00
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 0% 23 $0.00
87641 0% 12 $0.00
90662 0% 21 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEONARD, STEVEN (PRESIDENT/C.E.O.)